Literature DB >> 21168901

Intravesical electromotive botulinum toxin type A administration: part I--Experimental study.

Abdol-Mohammad Kajbafzadeh1, Laleh Montaser-Kouhsari, Hamed Ahmadi, Masoud Sotoudeh.   

Abstract

OBJECTIVES: To evaluate the depth and pattern of botulinum toxin type A (BTX-A) distribution throughout the rabbit bladder wall by intravesical electromotive drug administration (EMDA).
METHODS: In an experimental study, 15 male healthy New Zealand white rabbits were allocated in 3 groups of BTX-A injection into the bladder wall, intravesical electromotive BTX-A administration (BTX-A/EMDA), and electromotive saline administration. In BTX-A injection group, a total dose of 10 IU/kg of BTX-A (Dysport) was injected into 10 sites of bladder detrusor muscle using a 6-Fr rigid cystoscope. In BTX-A/EMDA group, a current generator delivered a total of 2-2.4 mA with a frequency of 2.5 kHz to a fully distended bladder containing 10 IU/kg BTX-A for 15 minutes. In electromotive saline administration group, electrical current with the same characteristics was delivered to a saline-filled bladder. Three different specimens from the bladder dome, posterior, and anterior bladder walls were obtained and submitted for pathologic evaluation.
RESULTS: Pattern of immunohistochemical staining in bladder specimens from BTX-A injection group was weak and heterogeneous in the urothelium, interstitium, and muscular layers. However, in BTX-A/EMDA group the staining was uniform in urothelium, interstitial and muscular layers in all submitted specimens. In electromotive saline administration group, the urothelium, interstitium, and muscular layers were intact.
CONCLUSIONS: There is no clinical or experimental report of intravesical BTX-A/EMDA in the literature. This method demonstrated deep and homogenous penetration of the toxin throughout the urinary bladder layers compared with the intravesical BTX-A injection.
Copyright © 2011 Elsevier Inc. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 21168901     DOI: 10.1016/j.urology.2010.09.036

Source DB:  PubMed          Journal:  Urology        ISSN: 0090-4295            Impact factor:   2.649


  8 in total

1.  Advances in the management of neurogenic detrusor overactivity in multiple sclerosis.

Authors:  Gael J Yonnet; Anette S Fjeldstad; Noel G Carlson; John W Rose
Journal:  Int J MS Care       Date:  2013

Review 2.  Updates in the management of the overactive bladder in patients with myelomeningocele.

Authors:  Gregory E Dean; Christopher Long
Journal:  Curr Urol Rep       Date:  2011-12       Impact factor: 3.092

Review 3.  Botulinum toxin A's expanding role in the management of pediatric lower urinary tract dysfunction.

Authors:  Tarek Hassouna; Joseph M Gleason; Armando J Lorenzo
Journal:  Curr Urol Rep       Date:  2014-08       Impact factor: 3.092

4.  The effect of botulinum toxin on ureteral inflammation.

Authors:  Kevin Krughoff; Faith L Anderson; Scott Palisoul; Alison L Young; Jason R Pettus; Karen L Moodie; Christopher Ogomo; Steven S Tau; Rachel A Moses; Matthew C Havrda; David R Chavez
Journal:  World J Urol       Date:  2020-07-21       Impact factor: 4.226

Review 5.  Botulinum toxin therapy in children with neurogenic detrusor overactivity.

Authors:  Jasmin Katrin Badawi
Journal:  Turk J Urol       Date:  2019-11-29

Review 6.  The Expanding Therapeutic Utility of Botulinum Neurotoxins.

Authors:  Elena Fonfria; Jacquie Maignel; Stephane Lezmi; Vincent Martin; Andrew Splevins; Saif Shubber; Mikhail Kalinichev; Keith Foster; Philippe Picaut; Johannes Krupp
Journal:  Toxins (Basel)       Date:  2018-05-18       Impact factor: 4.546

7.  Development of an in vitro model to measure bioactivity of botulinum neurotoxin A in rat bladder muscle strips.

Authors:  Janneke I M van Uhm; Goedele M A Beckers; Willem J van der Laarse; Eric J H Meuleman; Albert A Geldof; Jakko A Nieuwenhuijzen
Journal:  BMC Urol       Date:  2014-05-15       Impact factor: 2.264

8.  Botulinum Toxin Injection for Medically Refractory Neurogenic Bladder in Children: A Systematic Review.

Authors:  Shu-Yu Wu; Shang-Jen Chang; Stephen Shei-Dei Yang; Chun-Kai Hsu
Journal:  Toxins (Basel)       Date:  2021-06-28       Impact factor: 4.546

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.